BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alba C, Blanco A, Alarcón T. Antibiotic resistance in Helicobacter pylori. Curr Opin Infect Dis 2017;30:489-97. [PMID: 28704226 DOI: 10.1097/QCO.0000000000000396] [Cited by in Crossref: 71] [Cited by in F6Publishing: 34] [Article Influence: 17.8] [Reference Citation Analysis]
Number Citing Articles
1 Kim SY, Chung JW. Best Helicobacter pylori Eradication Strategy in the Era of Antibiotic Resistance. Antibiotics (Basel) 2020;9:E436. [PMID: 32717826 DOI: 10.3390/antibiotics9080436] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Yeh JY, Lin HJ, Kuo CJ, Feng CL, Chou CH, Lin CD, Wu HY, Li CY, Chiu CH, Lai CH. Campylobacter jejuni Cytolethal Distending Toxin C Exploits Lipid Rafts to Mitigate Helicobacter pylori-Induced Pathogenesis. Front Cell Dev Biol 2020;8:617419. [PMID: 33708766 DOI: 10.3389/fcell.2020.617419] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Hornburg D, Kruse T, Anderl F, Daschkin C, Semper RP, Klar K, Guenther A, Mejías-Luque R, Schneiderhan-Marra N, Mann M, Meissner F, Gerhard M. A mass spectrometry guided approach for the identification of novel vaccine candidates in gram-negative pathogens. Sci Rep 2019;9:17401. [PMID: 31758014 DOI: 10.1038/s41598-019-53493-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Muzaheed. Helicobacter pylori Oncogenicity: Mechanism, Prevention, and Risk Factors. ScientificWorldJournal 2020;2020:3018326. [PMID: 32765194 DOI: 10.1155/2020/3018326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Jiao L, Wang J, Ma H. Analysis of Helicobacter pylori's Antibiotic Resistance Rate and Research on Its Eradication Treatment Plan. Comput Math Methods Med 2021;2021:6009602. [PMID: 34899967 DOI: 10.1155/2021/6009602] [Reference Citation Analysis]
6 Silvan JM, Guerrero-Hurtado E, Gutiérrez-Docio A, Alarcón-Cavero T, Prodanov M, Martinez-Rodriguez AJ. Olive-Leaf Extracts Modulate Inflammation and Oxidative Stress Associated with Human H. pylori Infection. Antioxidants (Basel) 2021;10:2030. [PMID: 34943133 DOI: 10.3390/antiox10122030] [Reference Citation Analysis]
7 Yeh YC, Huang TH, Yang SC, Chen CC, Fang JY. Nano-Based Drug Delivery or Targeting to Eradicate Bacteria for Infection Mitigation: A Review of Recent Advances. Front Chem 2020;8:286. [PMID: 32391321 DOI: 10.3389/fchem.2020.00286] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 22.5] [Reference Citation Analysis]
8 Liu Y, Wang S, Yang F, Chi W, Ding L, Liu T, Zhu F, Ji D, Zhou J, Fang Y, Zhang J, Xiang P, Zhang Y, Zhao H. Antimicrobial resistance patterns and genetic elements associated with the antibiotic resistance of Helicobacter pylori strains from Shanghai. Gut Pathog 2022;14:14. [PMID: 35354484 DOI: 10.1186/s13099-022-00488-y] [Reference Citation Analysis]
9 Benigno TGDS, Ribeiro Junior HL, Azevedo OGR, Pinheiro RF, Oliveira RTG, Maciel FS, Oliveira EL, Queiroz DMM, Braga LLBC. Clarithromycin-resistant H. pylori primary strains and virulence genotypes in the Northeastern region of Brazil. Rev Inst Med Trop Sao Paulo 2022;64:e47. [PMID: 35858038 DOI: 10.1590/S1678-9946202264047] [Reference Citation Analysis]
10 Liu Y, Yang F, Wang S, Chi W, Ding L, Liu T, Zhu F, Ji D, Zhou J, Fang Y, Zhang J, Xiang P, Zhang Y, Zhao H. HopE and HopD Porin-Mediated Drug Influx Contributes to Intrinsic Antimicrobial Susceptibility and Inhibits Streptomycin Resistance Acquisition by Natural Transformation in Helicobacter pylori. Microbiol Spectr 2022;:e0198721. [PMID: 35234510 DOI: 10.1128/spectrum.01987-21] [Reference Citation Analysis]
11 Mayderry DW. Letter in response to Relationship between primary eradication of Helicobacter pylori and drinking habits in women: collaborative research between a pharmacy and a clinic. Epidemiol Infect 2020;148:e2. [PMID: 31918787 DOI: 10.1017/S095026881900219X] [Reference Citation Analysis]
12 Zhong Y, Tang L, Deng Q, Jing L, Zhang J, Zhang Y, Yu F, Ou Y, Guo S, Huang B, Cao H, Huang P, Xu Y. Unraveling the Novel Effect of Patchouli Alcohol Against the Antibiotic Resistance of Helicobacter pylori. Front Microbiol 2021;12:674560. [PMID: 34149664 DOI: 10.3389/fmicb.2021.674560] [Reference Citation Analysis]
13 Silvan JM, Gutierrez-Docio A, Guerrero-Hurtado E, Domingo-Serrano L, Blanco-Suarez A, Prodanov M, Alarcon-Cavero T, Martinez-Rodriguez AJ. Pre-Treatment with Grape Seed Extract Reduces Inflammatory Response and Oxidative Stress Induced by Helicobacter pylori Infection in Human Gastric Epithelial Cells. Antioxidants (Basel) 2021;10:943. [PMID: 34208004 DOI: 10.3390/antiox10060943] [Reference Citation Analysis]
14 Arenas A, Serrano C, Quiñones L, Harris P, Sandoval M, Lavanderos M, Sepúlveda R, Maquilón S, Echeverría A, Ríos C, Fuentes-López E, Rojas L, Jorquera A, Pizarro M, Camargo MC, Riquelme A. High prevalence of clarithromycin resistance and effect on Helicobacter pylori eradication in a population from Santiago, Chile: cohort study and meta-analysis. Sci Rep 2019;9:20070. [PMID: 31882676 DOI: 10.1038/s41598-019-56399-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
15 Gao W, Zhang X, Yin Y, Yu S, Wang L. Different dose of new generation proton pump inhibitors for the treatment of Helicobacter pylori infection: A meta-analysis. Int J Immunopathol Pharmacol 2021;35:20587384211030397. [PMID: 34250840 DOI: 10.1177/20587384211030397] [Reference Citation Analysis]
16 Miqueleiz-zapatero A, Alba-rubio C, Domingo-garcía D, Cantón R, Gómez-garcía de la Pedrosa E, Aznar-cano E, Leiva J, Montes M, Sánchez-romero I, Rodríguez-díaz JC, Alarcón-cavero T. First national survey on the diagnosis of Helicobacter pylori infection in Clinical Microbiology Laboratories in Spain. Enfermedades infecciosas y microbiologia clinica (English ed ) 2020;38:410-6. [DOI: 10.1016/j.eimce.2019.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Palau M, Piqué N, Ramírez-Lázaro MJ, Lario S, Calvet X, Miñana-Galbis D. Whole-Genome Sequencing and Comparative Genomics of Three Helicobacter pylori Strains Isolated from the Stomach of a Patient with Adenocarcinoma. Pathogens 2021;10:331. [PMID: 33809022 DOI: 10.3390/pathogens10030331] [Reference Citation Analysis]
18 Ranjbar R, Farsani FY, Dehkordi FS. Phenotypic analysis of antibiotic resistance and genotypic study of the vacA, cagA, iceA, oipA and babA genotypes of the Helicobacter pylori strains isolated from raw milk. Antimicrob Resist Infect Control. 2018;7:115. [PMID: 30288255 DOI: 10.1186/s13756-018-0409-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
19 Mukai R, Handa O, Suyama Y, Majima A, Naito Y. Effectiveness of including probiotics to Helicobacter pylori eradication therapies. J Clin Biochem Nutr 2020;67:102-4. [PMID: 32801475 DOI: 10.3164/jcbn.20-37] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Miftahussurur M, Aftab H, Shrestha PK, Sharma RP, Subsomwong P, Waskito LA, Doohan D, Fauzia KA, Yamaoka Y. Effective therapeutic regimens in two South Asian countries with high resistance to major Helicobacter pylori antibiotics. Antimicrob Resist Infect Control 2019;8:40. [PMID: 30815255 DOI: 10.1186/s13756-019-0482-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
21 Angsantikul P, Thamphiwatana S, Zhang Q, Spiekermann K, Zhuang J, Fang RH, Gao W, Obonyo M, Zhang L. Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against Helicobacter pylori infection. Adv Ther (Weinh) 2018;1:1800016. [PMID: 30320205 DOI: 10.1002/adtp.201800016] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
22 Ogaly HA, Alsherbiny MA, El Badawy SA, Abd-elsalam RM, Guang Li C, Azouz AA. Gastroprotective effects and metabolomic profiling of Chasteberry fruits against indomethacin-induced gastric injury in rats. Journal of Functional Foods 2021;86:104732. [DOI: 10.1016/j.jff.2021.104732] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Han L, Shu X, Wang J. Helicobacter pylori-Mediated Oxidative Stress and Gastric Diseases: A Review. Front Microbiol 2022;13:811258. [PMID: 35211104 DOI: 10.3389/fmicb.2022.811258] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Miqueleiz-Zapatero A, Alba-Rubio C, Domingo-García D, Cantón R, Gómez-García de la Pedrosa E, Aznar-Cano E, Leiva J, Montes M, Sánchez-Romero I, Rodríguez-Díaz JC, Alarcón-Cavero T; Grupo de Trabajo de Diagnóstico Microbiológico de Helicobacter pylori., Integrantes del Grupo de Trabajo de Diagnóstico Microbiológico de Helicobacter pylori Andalucía., Aragón., Principado de Asturias., Islas Baleares., Canarias., Cantabria., Castilla y León., Castilla-La Mancha., Cataluña., Comunidad Valenciana., Extremadura., Galicia., Comunidad de Madrid., Comunidad Foral de Navarra., País Vasco., La Rioja. First national survey of the diagnosis of Helicobacter pylori infection in Clinical Microbiology Laboratories in Spain. Enferm Infecc Microbiol Clin (Engl Ed) 2020;38:410-6. [PMID: 31987710 DOI: 10.1016/j.eimc.2019.11.008] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
25 Lai C, Lin T, Huang M, Li S, Wu H, Chiu Y, Yang C, Chiu C, Lai H. Gut Commensal Parabacteroides goldsteinii MTS01 Alters Gut Microbiota Composition and Reduces Cholesterol to Mitigate Helicobacter pylori-Induced Pathogenesis. Front Immunol 2022;13:916848. [DOI: 10.3389/fimmu.2022.916848] [Reference Citation Analysis]
26 Zhao Y, Li Y, Luan Z, Ma C, Yang L, Zhang W, Shi C. Establishment of a TaqMan-MGB probe multiplex real-time PCR system for one-step levofloxacin and clarithromycin resistant Helicobacter pylori detection. J Microbiol Methods 2021;192:106393. [PMID: 34919971 DOI: 10.1016/j.mimet.2021.106393] [Reference Citation Analysis]
27 Karmakar P, Gaitonde V. Promising Recent Strategies with Potential Clinical Translational Value to Combat Antibacterial Resistant Surge. Medicines (Basel) 2019;6:E21. [PMID: 30709019 DOI: 10.3390/medicines6010021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 Miftahussurur M, Waskito LA, Fauzia KA, Mahmudah I, Doohan D, Adnyana IK, Khomsan A, Ratnasari N, Rezkitha YAA. Overview of Helicobacter pylori Infection in Indonesia: What Distinguishes It from Countries with High Gastric Cancer Incidence? Gut Liver 2021;15:653-65. [PMID: 32616679 DOI: 10.5009/gnl20019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Landlinger C, Oberbauer V, Podpera Tisakova L, Schwebs T, Berdaguer R, Van Simaey L, Vaneechoutte M, Corsini L. Preclinical Data on the Gardnerella-Specific Endolysin PM-477 Indicate Its Potential to Improve the Treatment of Bacterial Vaginosis through Enhanced Biofilm Removal and Avoidance of Resistance. Antimicrob Agents Chemother 2022;:e0231921. [PMID: 35416708 DOI: 10.1128/aac.02319-21] [Reference Citation Analysis]
30 Do AD, Su CH, Hsu YM. Antagonistic Activities of Lactobacillus rhamnosus JB3 Against Helicobacter pylori Infection Through Lipid Raft Formation. Front Immunol 2021;12:796177. [PMID: 35095872 DOI: 10.3389/fimmu.2021.796177] [Reference Citation Analysis]
31 Mukai R, Handa O, Suyama Y, Majima A, Naito Y. Effectiveness of including probiotics to Helicobacter pylori eradication therapies. J Clin Biochem Nutr 2020;67:102-4. [PMID: 32801475 DOI: 10.3164/jcbn.20-37] [Reference Citation Analysis]
32 Epstein TD, Wu B, Moulton KD, Yan M, Dube DH. Sugar-Modified Analogs of Auranofin Are Potent Inhibitors of the Gastric Pathogen Helicobacter pylori. ACS Infect Dis 2019;5:1682-7. [PMID: 31487153 DOI: 10.1021/acsinfecdis.9b00251] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
33 Lin CC, Huang WC, Su CH, Lin WD, Wu WT, Yu B, Hsu YM. Effects of Multi-Strain Probiotics on Immune Responses and Metabolic Balance in Helicobacter pylori-Infected Mice. Nutrients 2020;12:E2476. [PMID: 32824501 DOI: 10.3390/nu12082476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Kalfus IN, Graham DY, Riff DS, Panas RM. Rifabutin-Containing Triple Therapy (RHB-105) for Eradication of Helicobacter pylori: Randomized ERADICATE Hp Trial. Antibiotics (Basel) 2020;9:E685. [PMID: 33050205 DOI: 10.3390/antibiotics9100685] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
35 Lien HM, Wu HY, Hung CL, Chen CJ, Wu CL, Chen KW, Huang CL, Chang SJ, Chen CC, Lin HJ, Lai CH. Antibacterial activity of ovatodiolide isolated from Anisomeles indica against Helicobacter pylori. Sci Rep 2019;9:4205. [PMID: 30862888 DOI: 10.1038/s41598-019-40735-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
36 Camorlinga-Ponce M, Gómez-Delgado A, Aguilar-Zamora E, Torres RC, Giono-Cerezo S, Escobar-Ogaz A, Torres J. Phenotypic and Genotypic Antibiotic Resistance Patterns in Helicobacter pylori Strains From Ethnically Diverse Population in México. Front Cell Infect Microbiol 2020;10:539115. [PMID: 33643927 DOI: 10.3389/fcimb.2020.539115] [Reference Citation Analysis]
37 Choi YI, Chung JW, Kim KO, Kwon KA, Kim YJ, Kim JH, Seo JY, Park DK. Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients. World J Gastroenterol 2021; 27(31): 5247-5258 [PMID: 34497448 DOI: 10.3748/wjg.v27.i31.5247] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Breijyeh Z, Jubeh B, Karaman R. Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It. Molecules. 2020;25. [PMID: 32187986 DOI: 10.3390/molecules25061340] [Cited by in Crossref: 79] [Cited by in F6Publishing: 64] [Article Influence: 39.5] [Reference Citation Analysis]
39 Ji J, Yang H. Using Probiotics as Supplementation for Helicobacter pylori Antibiotic Therapy.Int J Mol Sci. 2020;21. [PMID: 32046317 DOI: 10.3390/ijms21031136] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
40 Kipritci Z, Gurol Y, Celik G. Antibiotic Resistance Results of Helicobacter pylori in a University Hospital: Comparison of the Hybridization Test and Real-Time Polymerase Chain Reaction. Int J Microbiol 2020;2020:8853298. [PMID: 33488727 DOI: 10.1155/2020/8853298] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Quinn L, Sheh A, Ellis JL, Smith DE, Booth SL, Fu X, Muthupalani S, Ge Z, Puglisi DA, Wang TC, Gonda TA, Holcombe H, Fox JG. Helicobacter pylori antibiotic eradication coupled with a chemically defined diet in INS-GAS mice triggers dysbiosis and vitamin K deficiency resulting in gastric hemorrhage. Gut Microbes 2020;11:820-41. [PMID: 31955643 DOI: 10.1080/19490976.2019.1710092] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
42 Lee M, Chung JY, Kim KY, Im W, Kim M. Two-weeks repeated-dose oral toxicity study of Pediococcus acidilactici J9 in a mice model. BMC Microbiol 2020;20:372. [PMID: 33297964 DOI: 10.1186/s12866-020-02055-4] [Reference Citation Analysis]
43 Gong M, Han Y, Wang X, Tao H, Meng F, Hou B, Sun BB, Wang G. Effect of Temperature on Metronidazole Resistance in Helicobacter pylori. Front Microbiol 2021;12:681911. [PMID: 34093508 DOI: 10.3389/fmicb.2021.681911] [Reference Citation Analysis]
44 Bilello J, Okereke I. Impact of Environmental and Pharmacologic Changes on the Upper Gastrointestinal Microbiome. Biomedicines 2021;9:617. [PMID: 34072493 DOI: 10.3390/biomedicines9060617] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Chen YH, Tsai WH, Wu HY, Chen CY, Yeh WL, Chen YH, Hsu HY, Chen WW, Chen YW, Chang WW, Lin TL, Lai HC, Lin YH, Lai CH. Probiotic Lactobacillus spp. act Against Helicobacter pylori-induced Inflammation. J Clin Med. 2019;8. [PMID: 30646625 DOI: 10.3390/jcm8010090] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
46 Dey TK, Karmakar BC, Sarkar A, Paul S, Mukhopadhyay AK. A Mouse Model of Helicobacter pylori Infection. Methods Mol Biol 2021;2283:131-51. [PMID: 33765316 DOI: 10.1007/978-1-0716-1302-3_14] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Hallur V, Panigrahi M, Sable M, Ghosh M, Mohanty S, Purkait S, Praharaj A. Low clarithromycin resistance in virulent Helicobacter pylori from dyspeptic patients at a tertiary care centre in Odisha. Indian Journal of Medical Microbiology 2022. [DOI: 10.1016/j.ijmmb.2022.02.008] [Reference Citation Analysis]
48 Silvan JM, Gutiérrez-Docio A, Moreno-Fernandez S, Alarcón-Cavero T, Prodanov M, Martinez-Rodriguez AJ. Procyanidin-Rich Extract from Grape Seeds as a Putative Tool against Helicobacter pylori. Foods 2020;9:E1370. [PMID: 32993186 DOI: 10.3390/foods9101370] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
49 Deng G, Wu Y, Song Z, Li S, Du M, Deng J, Xu Q, Deng L, Bahlol HS, Han H. Tea Polyphenol Liposomes Overcome Gastric Mucus to Treat Helicobacter Pylori Infection and Enhance the Intestinal Microenvironment. ACS Appl Mater Interfaces 2022;14:13001-12. [PMID: 35266695 DOI: 10.1021/acsami.1c23342] [Reference Citation Analysis]
50 Sánchez-Alonzo K, Arellano-Arriagada L, Castro-Seriche S, Parra-Sepúlveda C, Bernasconi H, Benavidez-Hernández H, Campos VL, Sáez K, Smith CT, García-Cancino A. Temperatures Outside the Optimal Range for Helicobacter pylori Increase Its Harboring within Candida Yeast Cells. Biology (Basel) 2021;10:915. [PMID: 34571792 DOI: 10.3390/biology10090915] [Reference Citation Analysis]
51 Kobatake T, Ogino K, Sakae H, Gotoh K, Watanabe A, Matsushita O, Okada H, Yokota K. Antibacterial Effects of Disulfiram in Helicobacter pylori. Infect Drug Resist 2021;14:1757-64. [PMID: 34012274 DOI: 10.2147/IDR.S299177] [Reference Citation Analysis]
52 Cheha KM, Dib SOA, Alhalabi MM. Pilot study: Comparing efficacy of 14-day triple therapy Clarithromycin versus levofloxacin on eradication of Helicobacter pylori infection in Syrian population single-center experience. Avicenna J Med 2018;8:14-7. [PMID: 29404268 DOI: 10.4103/ajm.AJM_70_17] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]